AU2002242657A1 - Local use of essential oils for treating badly healed wounds - Google Patents

Local use of essential oils for treating badly healed wounds

Info

Publication number
AU2002242657A1
AU2002242657A1 AU2002242657A AU2002242657A AU2002242657A1 AU 2002242657 A1 AU2002242657 A1 AU 2002242657A1 AU 2002242657 A AU2002242657 A AU 2002242657A AU 2002242657 A AU2002242657 A AU 2002242657A AU 2002242657 A1 AU2002242657 A1 AU 2002242657A1
Authority
AU
Australia
Prior art keywords
essential oils
treating
local use
healed wounds
badly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002242657A
Inventor
Otto Greither
Markus M. Heiss
Anwar Tarabichi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WALTER SCHOENENBERGER PFLANZENSAFTWERK GmbH AND CO KG
Original Assignee
WALTER SCHOENENBERGER PFLANZEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WALTER SCHOENENBERGER PFLANZEN filed Critical WALTER SCHOENENBERGER PFLANZEN
Publication of AU2002242657A1 publication Critical patent/AU2002242657A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/14Cupressaceae (Cypress family), e.g. juniper or cypress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to the use of essential oils for the local treatment or prophylaxis of badly healed wounds.
AU2002242657A 2001-01-10 2002-01-10 Local use of essential oils for treating badly healed wounds Abandoned AU2002242657A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10100811.2 2001-01-10
DE10100811A DE10100811A1 (en) 2001-01-10 2001-01-10 Use of essential oils for the topical treatment or prophylaxis of wound healing disorders
PCT/EP2002/000185 WO2002055096A2 (en) 2001-01-10 2002-01-10 Local use of essential oils for treating badly healed wounds

Publications (1)

Publication Number Publication Date
AU2002242657A1 true AU2002242657A1 (en) 2002-07-24

Family

ID=7670130

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002242657A Abandoned AU2002242657A1 (en) 2001-01-10 2002-01-10 Local use of essential oils for treating badly healed wounds

Country Status (5)

Country Link
EP (1) EP1357926B1 (en)
AT (1) ATE270895T1 (en)
AU (1) AU2002242657A1 (en)
DE (2) DE10100811A1 (en)
WO (1) WO2002055096A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10256774A1 (en) * 2002-12-05 2004-06-24 Lts Lohmann Therapie-Systeme Ag Medicament for transmucosal or transdermal drug administration, containing combination of monoterpene and polyol, e.g. menthol and propanediol, as resorption improvers
BRPI0702622A8 (en) * 2007-03-16 2016-11-16 Univ Estadual De Maringa PHARMACEUTICAL COMPOSITIONS WITH ANTIFUNGAL ACTIVITY CONTAINING CYMBOPOGON NARDUS EXTRACTS, PROCESS FOR OBTAINING CYMBOPOGON NARDUS EXTRACTS AND THEIR USES
CN102920818B (en) * 2012-11-03 2014-06-11 牛德寿 Formula of medicine for treating burn, scald and cold injury
US20150017227A1 (en) * 2013-07-11 2015-01-15 Epitop, Inc. Methods and Compositions for Treating Skin Diseases and Conditions
CN104107297A (en) * 2014-08-12 2014-10-22 潘阿海 Paste for treating intractable ulcer
CN112353867A (en) * 2020-10-14 2021-02-12 曼秀雷敦(中国)药业有限公司 Natural plant bacteriostatic spray and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662939B1 (en) * 1990-06-08 1992-09-18 Beaussier Yann ANTI-INFLAMMATORY GEL AND ITS MANUFACTURING METHOD.
AT400395B (en) * 1991-09-05 1995-12-27 Haerpfer Horn Herta Mag AGENT FOR CARE OF THE FUR, THE SKIN AND IF NECESSARY OF THE HORSES OF HORSES
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
CH688787A5 (en) * 1995-09-05 1998-03-31 Dieter Linsig Synergistic mixture of essential oils or essences

Also Published As

Publication number Publication date
WO2002055096A3 (en) 2002-11-07
DE50200626D1 (en) 2004-08-19
DE10100811A1 (en) 2002-07-18
WO2002055096A2 (en) 2002-07-18
EP1357926B1 (en) 2004-07-14
EP1357926A2 (en) 2003-11-05
ATE270895T1 (en) 2004-07-15
WO2002055096A8 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
AU2001278003A1 (en) Bacteriophage having multiple host range
EP1487877A4 (en) Compositions and methods for the diagnosis and treatment of tumor
ZA200309808B (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003073999A3 (en) Pini-modulating compounds and methods of use thereof
AU3831301A (en) Method for treating ocular pain
WO2003074550A3 (en) Pin1-modulating compounds and methods of use thereof
MXPA05005107A (en) Compositions and methods for the diagnosis and treatment of tumor.
NZ517616A (en) Use of retigabin for treating neuropathic pain
WO2006110760A3 (en) Compositions and methods for the diagnosis and treatment of tumor
IL142900A0 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
WO2003007921A3 (en) Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases
HUP0401672A3 (en) Low concentration of peroxide for treating or preventing vaginal infections
AU2002242657A1 (en) Local use of essential oils for treating badly healed wounds
AP2001002248A0 (en) Method for treating COPD.
WO2003061704A3 (en) Combination therapy for the treatment of bacterial infections
AU2002231777A1 (en) Use of mglur5 antagonists for the treatment of pruritic conditions
AU2003249818A1 (en) Process for the treatment of waste oils
AU2001265876A1 (en) Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases
AU2001273759A1 (en) Essential oils and chemically related species for the treatment of increased bone resorption
YU22802A (en) Isonipectoamides for the treatment of integrinmediates disorders
AU2002365621A1 (en) Composition for treating the surface of the skin
WO2003011309A3 (en) Pharmaceutical composition for treating hypercholesterolaemia
AU2002251202A1 (en) Intimins for the prevention or treatment of infections: i
AU2003246728A1 (en) Calcium lactate and whey permeate for lowering the triglyceride level
WO2003014128A3 (en) Tumour inhibiting cerium compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase